Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Injections × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 35 Breast Neoplasms 18 Advanced Solid Tumors 16 Myelodysplastic Syndromes 14 Advanced Solid Tumor 11 Recurrence 9 Carcinoma, Non-Small-Cell Lung 9 Leukemia, Myelomonocytic, Chronic 8 Neoplasms 7 Myeloproliferative Disorders 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Triple Negative Breast Neoplasms 5 Solid Tumor 5 Ovarian Neoplasms 5 Advanced Solid Tumour 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Lymphoma, B-Cell 4 Lung Neoplasms 4 Carcinoma, Hepatocellular 4 Advanced Malignant Solid Tumor 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Prostatic Neoplasms 3 Primary Myelofibrosis 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Myelodysplastic-Myeloproliferative Diseases 3

Interventions

fludarabine 4 Cisplatin 4 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 durvalumab 2 cobimetinib 2 atezolizumab 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1 pertuzumab 1 gilteritinib 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡